EI
IGMS

Ellevest Inc’s IGM Biosciences IGMS Stock Holding History

Ellevest Inc’s Portfolio IGMS Stock Details IGMS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-11
Closed -$151 – 943
2023
Q1 		$151 Sell
11
-18
-62% -$372 ﹤0.01% 1790
2022
Q4 		$493 Sell
29
-42
-59% -$840 ﹤0.01% 1622
2022
Q3 		$2K Sell
71
-20
-22% -$404 ﹤0.01% 1344
2022
Q2 		$2K Buy
91
+83
+1,038% +$1.48K ﹤0.01% 1160
2022
Q1 		$0 Buy
+8
New +$149 ﹤0.01% 1511

Other funds holding IGMS

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Ellevest Inc's IGMS Position: Q2 2023 in Review

Ellevest Inc sold out of IGM Biosciences (IGMS) in Q2 2023, closing a stake of 11 shares — an estimated $151 sold.

Ellevest Inc first reported a position in IGMS in Q1 2022 and held it in 5 quarters. The position peaked at $2K in Q3 2022. 79 funds tracked by Wall St. Rank hold IGMS as of Q2 2023.

  • Ellevest Inc reported no remaining IGM Biosciences position as of Q2 2023 after selling out during the quarter.
  • Ellevest Inc sold 11 IGM Biosciences shares in Q2 2023, an estimated $151.
  • Ellevest Inc first reported a position in IGM Biosciences in Q1 2022 and held it in 5 quarters.
  • Ellevest Inc's IGM Biosciences position peaked at $2K in Q3 2022.
  • 79 funds tracked by Wall St. Rank held IGM Biosciences as of Q2 2023.

Based on Ellevest Inc's 13F filing for Q2 2023, filed 9 Aug 2023.